Stock Fundamentals

Company Information

Company Name
PHARMESIS INTERNATIONAL LTD.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
SG
Currency: SGD
Full Time Employees: 0
Phone: 65 6846 0766
Fiscal Year End: December
Description:

Pharmesis International Ltd., an investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People's Republic of China. The company operates through three segments: Western drugs/TCH Procurement, TCM formulated drugs/IP Rental, and Distribution. It provides prescribed products and over-the-counter drugs. The company offers Anethole Trithione for the treatment of illness relating to the liver and gall bladder; Xiao Shi Jian Pi to treat flatus, inappetency, dyspepsy, and spleen weakness; and Xiao Luo Tong for rheumatoid arthritis and other rheumatic diseases treatment. It also provides Gansu for acute and chronic hepatitis treatment; Er Ding granules to treat jaundice and clear heat toxin; Shulinghou for the treatment of acute and chronic pharyngitis, laryngitis, sore throat, and hoarseness; Fu Yang for the treatment skin pruritus and urticaria; and Xiong Dan Chuan Bei for the treatment of phlegm and cough. Further, the company distributes chemical drugs, biological raw products, TCM products, antibiotics, and antibiotic agents. The company provides western medicine products under the Kinna brand name; and TCM formulated products under the Longlife brand name. Pharmesis International Ltd. was founded in 1996 and is based in Singapore.

Address:

5 Kallang Sector, Singapore, Singapore, 349279

Directors & Officers

Name Title Year Born
Mr. Xuedan Wu CEO & Executive Director 1963
Mr. Chan Hoe Liang Financial Controller 1977
Ms. Moi Heyang Lin Joint Company Secretary NA
Ms. Pei Chan Tang Joint Company Secretary NA

Shares Statistics

Shares Outstanding: 31.70M
Shares Float: 6.77M
% Insiders: 7,864.10%
% Institutions: 0.00%

Valuation Metrics

Enterprise Value: $15.32M
Trailing P/E: 0.00
Forward P/E: 10.00

Financial Highlights

Market Cap: $13.16M
EBITDA: $-3.01M
Book Value: $0.33
Dividend/Share: $0.00
Dividend Yield: 0.00%
Earnings/Share: $-0.03
Profit Margin: -9.83%
Operating Margin: -25.79%
ROA (TTM): -3.14%
ROE (TTM): -7.35%
Revenue (TTM): $43.75M
Revenue/Share (TTM): $1.38
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -62.20%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 0.96x 0.00x 0.42x -7.71x 0.00x
2024-12-31 1.05x 0.00x 0.47x 3.07x 0.00x
2023-12-31 1.09x 0.00x 0.37x -3.02x 0.00x
2022-12-31 1.12x 0.00x 0.42x -2.70x 0.00x
2021-12-31 1.21x 0.00x 0.35x 1.02x 0.00x
2020-12-31 1.14x 0.00x 0.38x -5.38x 0.00x
2019-12-31 1.33x 0.24x 0.34x -19.87x -0.91x
2018-12-31 2.76x 0.17x 0.30x 7.95x 1.73x
2017-12-31 2.59x 0.17x 0.29x N/A 11.95x
2016-12-31 3.95x 0.16x 0.26x N/A -4.02x
2015-12-31 4.57x 0.16x 0.23x N/A 5.14x
2014-12-31 6.65x 0.06x 0.13x N/A -1.32x
2013-12-31 15.19x 0.00x 0.05x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about BFK.SG!